Triple negative breast cancer accounts for 15% of cases but causes a disproportionate number of deaths. Learn about symptoms ...

Find out more about the overall breast cancer treatment landscape, as biotech companies make progress with different ...

testing positive for a germline BRCA1 variant. Germline BRCA 1 and BRCA 2 test results were available for all 450 men. These revealed 27 germline BRCA2 variants (6%), but only two germline BRCA1 ...

testing positive for a germline BRCA1 variant. Germline BRCA 1 and BRCA 2 test results were available for all 450 men. These revealed 27 germline BRCA2 variants (6%), but only 2 germline BRCA1 ...

Cancer is a disease that profoundly impacts lives, often leaving individuals and families with uncertainty and fear. However, ...

Two sisters recently went viral on TikTok after publicly declaring their decision to get double mastectomies together. The decision came after learning of their family's long history with breast ...

TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.

Aliya Omer, VP, US franchise head, breast cancer, AstraZeneca, discusses Lynparza’s role in reducing the risk of invasive disease recurrence or death in HR-positive breast cancer patients.

Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...

Patients in the pembrolizumab-olaparib arm had clinically meaningful improvements in PFS over patients in the control arm.